GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a truly shift in how we treat type 2 diabetes . These new therapies work by imitating the body’s inherent GLP-1 substance , which https://maximusbookmarks.com/story21810377/glp-1-a-revolutionary-approach-in-diabetes-care